Search

everythinglearnresearchcommunity

for

Search:↓

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Setipiprant did not significantly improve hair growth in men with hair loss.

Butin is effective in treating vitiligo in mice.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Tofacitinib treatment is used for teenagers with alopecia areata.

Bimatoprost helps mouse hair grow by turning on a specific growth pathway.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Newly made nicotinamide compounds could potentially treat cancer.

Compound 7p shows strong potential as an anticancer agent.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

QLT0267 stops hair follicle cell growth and movement.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.